Cash Equivalents - Portage Biotech Inc (NASDAQ:PRTG) - Alpha Spread

Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 10.21 USD 3.03% Market Closed
Market Cap: 214.4m USD
Have any thoughts about
Portage Biotech Inc?
Write Note

Portage Biotech Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Portage Biotech Inc
Cash Equivalents Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Portage Biotech Inc
NASDAQ:PRTG
Cash Equivalents
$3.3m
CAGR 3-Years
-51%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Cash Equivalents
$4.9m
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Cash Equivalents
$111.3m
CAGR 3-Years
-30%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash Equivalents
$33.3m
CAGR 3-Years
-35%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Cash Equivalents
CA$9.4m
CAGR 3-Years
39%
CAGR 5-Years
52%
CAGR 10-Years
9%
Spectral Medical Inc
TSX:EDT
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Portage Biotech Inc's Cash Equivalents?
Cash Equivalents
3.3m USD

Based on the financial report for Jun 30, 2024, Portage Biotech Inc's Cash Equivalents amounts to 3.3m USD.

What is Portage Biotech Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-9%

Over the last year, the Cash Equivalents growth was -57%. The average annual Cash Equivalents growth rates for Portage Biotech Inc have been -51% over the past three years , -9% over the past five years .

Back to Top